Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Receivables - Other: 2016-2017

Historic Receivables - Other for Organogenesis Holdings (ORGO) over the last 2 years, with Dec 2017 value amounting to $250,000.

  • Organogenesis Holdings' Receivables - Other changed negligibly% to $250,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $250,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $250,000 for FY2017, which is negligibly% changed negligibly from last year.
  • Organogenesis Holdings' Receivables - Other amounted to $250,000 in FY2017, which was down 0.00% from $250,000 recorded in FY2016.
  • Organogenesis Holdings' Receivables - Other's 5-year high stood at $250,000 during FY2016, with a 5-year trough of $250,000 in FY2016.
  • For the 2-year period, Organogenesis Holdings' Receivables - Other averaged around $250,000, with its median value being $250,000 (2017).